中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders

文献类型:期刊论文

作者Kong, Qingyan1,2; Han, Buxin1,2,3
刊名EXPERT REVIEW OF NEUROTHERAPEUTICS
出版日期2024-05-03
卷号24期号:5页码:517-525
通讯作者邮箱hanbx@psych.ac.cn (buxin han)
关键词Anxiety disorders cognitive bias modification Chinese culture pharmacotherapy treatment
ISSN号1473-7175
DOI10.1080/14737175.2024.2334847
产权排序1
文献子类综述
英文摘要

IntroductionAnxiety disorders are characterized by widespread and persistent anxiety or recurrent panic attacks. As a result of their high prevalence, chronicity, and comorbidity, patients' quality of life and functioning are severely compromised. However, several patients do not receive treatment.Areas coveredThis review discusses the effectiveness, safety, and limitations of major medications and cognitive bias modification (CBM) for treating anxiety disorders. The possibility of combined treatment is also discussed in the literature. Furthermore, drawing on Chinese cultural perspectives, the authors suggest that anxiety can be recognized, measured, and coped with at three levels of skill (), vision (), and Tao ().Expert opinionThe combination of pharmacotherapy and CBM is possibly more effective in treating anxiety disorders than either treatment alone. However, clinicians and patients should participate in the joint decision-making process and consider comprehensive factors. Moderate anxiety has adaptive significance. In the coming years, by combining the downward analytical system of western culture with the upward integrative system of Chinese culture, a comprehensive understanding of anxiety and anxiety disorders should be established, rather than focusing only on their treatment.

收录类别SCI
WOS关键词SOCIAL ANXIETY ; PREGABALIN ; EFFICACY ; ATTENTION ; CARE ; COMORBIDITY ; FEAR ; PHARMACOLOGY ; PREVALENCE ; RECURRENCE
资助项目Social Science Foundation of China[20VYJ041]
WOS研究方向Neurosciences & Neurology ; Pharmacology & Pharmacy
语种英语
WOS记录号WOS:001195013400001
出版者TAYLOR & FRANCIS LTD
资助机构Social Science Foundation of China
源URL[http://ir.psych.ac.cn/handle/311026/47546]  
专题心理研究所_中国科学院心理健康重点实验室
通讯作者Han, Buxin
作者单位1.Chinese Acad Sci, Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China
2.Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China
3.Chinese Acad Sci, Inst Psychol, 16 Lincui Rd, Beijing 100101, Peoples R China
推荐引用方式
GB/T 7714
Kong, Qingyan,Han, Buxin. Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders[J]. EXPERT REVIEW OF NEUROTHERAPEUTICS,2024,24(5):517-525.
APA Kong, Qingyan,&Han, Buxin.(2024).Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders.EXPERT REVIEW OF NEUROTHERAPEUTICS,24(5),517-525.
MLA Kong, Qingyan,et al."Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders".EXPERT REVIEW OF NEUROTHERAPEUTICS 24.5(2024):517-525.

入库方式: OAI收割

来源:心理研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。